Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Holders of 5% or more of CALC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of CalciMedica, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CALC
HolderLatest formStakeChangeFirst filedLatest filingFiling
Alafi Capital Co LLC13D/A19.90%7.22M shares+2.80 ppfrom 17.10%Apr 1, 20254 filingsAug 24, 2026SEC
Bering Partners II GP, L.L.C.13D/A9.99%3.55M shares+3.09 ppfrom 6.90%Oct 29, 20253 filingsAug 21, 2026SEC
Armistice Capital, LLC13G9.99%3.41M sharesNewAug 14, 20261 filingAug 14, 2026SEC
Woodline Partners LP13G8.10%2.49M sharesNewAug 14, 20261 filingAug 14, 2026SEC
Valence Investments SPV VI, LLC13D/A6.40%1.97M shares–Mar 30, 20235 filingsJun 30, 2026SEC
Stonepine Capital Management, LLC13G6.00%2.15M shares+1.40 ppfrom 4.60%Jan 31, 20245 filingsAug 25, 2026SEC
CVI Investments, Inc.13G5.10%1.56M sharesNewJul 20, 20261 filingJul 20, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

63 Schedule 13D and 13G filings on CalciMedica, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CALC
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 25, 20264:22 PM ETStonepine Capital Management, LLCand 3 others13G6.00%2.15M shares+1.40 ppfrom 4.60%Aug 19, 2026SEC
Aug 24, 20265:02 PM ETAlafi Capital Co LLCand 1 other13D/A19.90%7.22M shares+2.80 ppfrom 17.10%Aug 19, 2026SEC
Aug 21, 20265:00 PM ETBering Partners II GP, L.L.C.and 3 others13D/A9.99%3.55M shares+3.09 ppfrom 6.90%Aug 19, 2026SEC
Aug 14, 202611:02 AM ETWoodline Partners LP13G8.10%2.49M sharesNewJun 30, 2026SEC
Aug 14, 202610:05 AM ETArmistice Capital, LLCand 1 other13G9.99%3.41M sharesNewJun 30, 2026SEC
Jul 20, 20265:32 PM ETCVI Investments, Inc.and 1 other13G5.10%1.56M sharesNewJun 23, 2026SEC
Jul 10, 20265:35 PM ETAlafi Capital Co LLCand 1 other13D17.10%5.24M shares+5.80 ppfrom 11.30%Jun 25, 2026SEC
Jul 2, 20268:31 PM ETBering Partners II GP, L.L.C.and 3 others13D6.90%2.11M shares+1.10 ppfrom 5.80%Jun 25, 2026SEC
Jun 30, 20265:56 PM ETValence Investments SPV VI, LLCand 4 others13D/A6.40%1.97M shares–Jun 25, 2026SEC
Jun 25, 20265:00 PM ETAvenue Venture Opportunities Fund II, L.P.and 4 others13G/A4.99%4.64M shares−3.88 ppfrom 8.87%Below 5%Jun 23, 2026SEC
May 20, 20265:40 PM ETChernett Jorey13G/A0.00%0 shares−7.90 ppfrom 7.90%Below 5%Mar 31, 2026SEC
May 8, 20265:00 PM ETSoleus Private Equity Fund III, L.P.and 8 others13G/A2.40%392.0K shares−5.10 ppfrom 7.50%Below 5%Mar 31, 2026SEC
Feb 6, 20266:43 PM ETFlynn James Eand 3 others13G/A4.34%653.3K shares–Below 5%Feb 6, 2026SEC
Dec 1, 20252:31 PM ETChernett Jorey13G7.90%1.13M sharesNewNov 24, 2025SEC
Nov 7, 20254:00 PM ETSoleus Private Equity Fund III, L.P.and 8 others13G/A7.50%1.08M shares–Sep 30, 2025SEC
Oct 29, 20253:11 PM ETBering Partners II GP, L.L.C.and 3 others13G5.80%663.2K sharesNewJan 23, 2024SEC
Sep 9, 20254:26 PM ETAvenue Venture Opportunities Fund II, L.P.and 4 others13G/A8.87%1.36M shares0.00 ppfrom 8.87%Sep 1, 2025SEC
Sep 2, 20257:10 PM ETAvenue Venture Opportunities Fund II, L.P.and 4 others13G/A8.87%1.36M shares+2.17 ppfrom 6.70%Sep 1, 2025SEC
Aug 5, 20257:32 PM ETAlafi Capital Co LLCand 1 other13G/A11.30%1.58M shares+1.70 ppfrom 9.60%Jul 22, 2025SEC
May 28, 20256:55 PM ETAvenue Venture Opportunities Fund II, L.P.and 4 others13G6.70%1.00M sharesNewFeb 28, 2025SEC
May 14, 20254:07 PM ETStonepine Capital Management, LLCand 3 others13G/A4.60%628.7K shares−0.80 ppfrom 5.40%Below 5%Mar 31, 2025SEC
Apr 1, 20258:53 PM ETAlafi Capital Co LLCand 1 other13G9.60%1.30M sharesNewMar 25, 2025SEC
Mar 3, 20255:01 PM ETAisling Capital V, LPand 4 others13G/A3.90%781.7K shares–Below 5%Mar 3, 2025SEC
Feb 14, 202510:56 AM ETRevelation Healthcare Fund I, L.P.and 4 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Dec 13, 20242:55 PM ETStonepine Capital Management, LLCand 3 others13G5.40%741.7K shares–Dec 6, 2024SEC
Nov 26, 2024Sanderling Venture Partners VI LP13DOld format–New–SEC
Nov 14, 2024Soleus Private Equity Fund III, L.P.13G/AOld format–––SEC
Nov 14, 2024Lytton Laurence W13G/AOld format–––SEC
Nov 13, 2024Stonepine Capital Management, LLC13G/AOld format–––SEC
Nov 6, 2024Valence Investments SPV VI, LLC13D/AOld format–––SEC
Jul 8, 2024Lytton Laurence W13GOld format–New–SEC
Feb 8, 2024Soleus Capital Master Fund, L.P.13G/AOld format–––SEC
Feb 8, 2024Valence Investments SPV VI, LLC13D/AOld format–––SEC
Feb 7, 2024BML Investment Partners, L.P.13G/AOld format–––SEC
Feb 5, 2024OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 1, 2024Aisling Capital V, LP13GOld format–New–SEC
Feb 1, 2024Flynn James E13GOld format–––SEC
Jan 31, 2024Stonepine Capital Management, LLC13GOld format–New–SEC
Jan 26, 2024Soleus Capital Master Fund, L.P.13GOld format–New–SEC
Nov 22, 2023Valence Investments SPV VI, LLC13D/AOld format–––SEC
May 23, 2023Flynn James E13D/AOld format–––SEC
Mar 30, 2023Valence Investments SPV VI, LLC13DOld format–New–SEC
Mar 30, 2023Revelation Healthcare Fund I, L.P.13GOld format–New–SEC
Mar 28, 2023Flynn James E13D/AOld format–––SEC
Mar 27, 2023Flynn James E13D/AOld format–––SEC
Mar 24, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 13, 2023Affamed Project Ltd13G/AOld format–––SEC
Feb 8, 2023BML Investment Partners, L.P.13G/AOld format–––SEC
Dec 1, 2022BML Investment Partners, L.P.13GOld format–New–SEC
Nov 23, 2022Flynn James E13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell CalciMedica, Inc. shares.

No Form 144 notices for CalciMedica, Inc. are on file.